Botulinum Toxin - Botox and Others

Botox® is licenced in the USA for blepharospasm, hemifacial spasm, cervical dystonia, severe hyperhidrosis of the axillae, dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients, two years of age or older, and for wrist and hand disability due to upper limb spasticity associated with stroke in adults.

In January 2014, Botox® was granted a licence for “the temporary improvement in the appearance of moderate to severe lateral canthal lines (crow`s feet lines) seen at maximum smile, either alone or when treated at the same time as glabellar (or frown) lines seen at maximum frown, in adult patients where these facial lines have an important psychological impact“. Other new products have been coming out on the market this past year and we are looking into those as well.

Botox® is one of  the leading brands of botulinum toxin type – A in terms of documented clinical trials and practical use around the world.

It was the first botulinum toxin to gain a cosmetic lisence endorsing its use for glabellar lines and wrinkles (as well as also being the first to get a licence for a crow’s feet indication). It is approved for glabellar treatments.  Set up a time to get your consultation as to what would be best for your needs. Starts at $12 per unit for the best quality work.

Find Out More